Section 174 & OBBBA

Section 174 & OBBBA: What Changed in 2025

The One Big Beautiful Bill Act (P.L. 119-21) reversed the TCJA's Section 174 capitalization requirement. Here's what changed, who it affects, and what your CPA needs to know for 2025 filings.

Signed July 4, 2025 · IRS Guidance: Rev. Proc. 2025-28

Last reviewed: June 2026Reviewed by: MainStreet's R&D Tax Credit team (licensed CPAs & Enrolled Agents)
Quick answer

What changed for Section 174 under OBBBA in 2025?

The One Big Beautiful Bill Act (OBBBA), enacted July 4, 2025, permanently restored immediate expensing of domestic research costs through new IRC §174A — reversing the TCJA rule that forced five-year amortization from 2022–2024. For tax years beginning after December 31, 2024, domestic R&E is deductible in the year incurred by default, with no election required; foreign R&E still amortizes over 15 years.

Small businesses (≤$31M average gross receipts under §448(c)) can apply §174A retroactively to 2022–2024 by amending those returns. All taxpayers can recover remaining unamortized 2022–2024 costs — fully in 2025 or ratably across 2025–2026 — using a method-change statement in lieu of Form 3115 per Rev. Proc. 2025-28. The §41 R&D tax credit is separate and was not repealed.

July 4, 2026 Deadline: Qualified small businesses (≤$31M average gross receipts) have until July 4, 2026 to file amended returns for 2022–2024 to retroactively deduct previously capitalized domestic R&E costs. Once this window closes, amended returns cannot be filed.

What Changed Under the OBBBA

The One Big Beautiful Bill Act (OBBBA), signed on July 4, 2025 (P.L. 119-21), reversed one of the most significant tax law changes affecting R&D since the TCJA: the mandatory capitalization of research and experimental (R&E) expenditures under IRC §174.

Under the TCJA (effective 2022–2024), companies were required to capitalize domestic R&E costs and amortize them over 5 years (15 years for foreign R&D). The OBBBA enacted new IRC §174A, which restores immediate, full expensing for domestic R&E costs beginning with tax years starting after December 31, 2024.

Bottom line: For 2025 and beyond, domestic R&D costs are fully deductible in the year incurred. The mandatory 5-year amortization period is gone for domestic costs. Foreign R&D amortization (15 years) remains unchanged.

TCJA vs. OBBBA: Side-by-Side Comparison

TopicUnder TCJA (2022–2024)Under OBBBA (2025+)
Domestic R&D TreatmentCapitalize & amortize over 5 yearsFully deductible in year incurred (new §174A)
Foreign R&D Treatment15-year amortizationStill 15-year amortization (unchanged)
Prior Unamortized Costs (2022–2024)No relief — continue amortizingCatch-up deduction: all in 2025, or split 2025–2026
Small Business Retroactive Relief (≤$31M avg. gross receipts)Not availableMay amend 2022–2024 returns to fully deduct; deadline July 4, 2026
Form 3115 RequirementRequired (or statement per Rev. Proc. 2023-08)Not required — attach statement per Rev. Proc. 2025-28
§280C Reduced Credit ElectionMust be on original return; not retroactiveEligible small businesses may make retroactively — deadline July 4, 2026

New IRC §174A: Immediate Expensing Restored

The OBBBA created a new code section, IRC §174A, which restores immediate expensing of domestic R&E expenditures. Key features:

  • Effective for tax years beginning after December 31, 2024
  • Applies to all domestic R&E expenditures — the same broad definition as §174 (broader than §41 QREs, including overhead and indirect costs)
  • Software development costs are still treated as R&E expenditures and eligible for §174A immediate expensing for domestic development
  • No amortization schedules required for domestic costs
Note for 2024 returns: If your 2024 tax year return has not yet been filed as of 2026, the §174 capitalization requirement still applies for that year. The OBBBA changes only take effect for tax years beginning after December 31, 2024. Confirm with your CPA which year is being addressed.

Catch-Up Deduction for 2022–2024 Balances

Taxpayers who capitalized domestic R&E costs under the TCJA (2022, 2023, 2024) have unamortized balances — costs that were capitalized but not yet deducted. The OBBBA provides a catch-up mechanism:

Option 1: Full Deduction in 2025

Deduct all unamortized 2022–2024 domestic R&E costs in a single catch-up deduction on the 2025 return. Best for companies wanting to maximize deductions in 2025.

Option 2: Split Equally Across 2025–2026

Split the unamortized balance equally between 2025 and 2026. Useful for managing taxable income across years or smoothing deductions.

No Form 3115 is required. A statement attached to the federal return (per Rev. Proc. 2025-28) is sufficient.

Small Business Retroactive Relief

Companies that qualify as "small businesses" under the §448(c) test (average annual gross receipts of $31 million or less for 2022–2024) have an additional option: filing amended returns for 2022, 2023, and/or 2024 to fully deduct R&E costs that were previously required to be capitalized.

  • Threshold: ≤ $31 million average annual gross receipts (§448(c) test) for 2022–2024
  • Deadline: July 4, 2026 (one year from OBBBA enactment)
  • Scope: Can amend 2022, 2023, and/or 2024 returns
  • Benefit: Full deduction of all previously capitalized domestic R&E costs for those years
This is a hard deadline. Once July 4, 2026 passes, small businesses cannot file amended returns to claim this relief. Companies that qualify should work with their CPA immediately.

Foreign R&D: Still 15-Year Amortization

The OBBBA did not change the treatment of foreign R&D expenditures. R&E costs incurred for research conducted outside the United States remain subject to 15-year amortization under the original §174 rules. CPAs should continue to prepare amortization schedules for foreign R&E costs.

Form 3115: Not Required for the Transition

Under previous guidance (Rev. Proc. 2023-08), some taxpayers used a Form 3115 (Application for Change in Accounting Method) to make accounting method changes related to §174. Under the OBBBA and Rev. Proc. 2025-28:

  • Form 3115 is not required to transition to immediate expensing under §174A
  • A statement attached to the federal return is sufficient
  • The same applies to the catch-up deduction for prior unamortized balances

§280C Election: Retroactive Option for Small Businesses

The §280C reduced credit election is typically irrevocable and must be made on a timely-filed return. However, the OBBBA provides a special retroactive window for small businesses: eligible small businesses may make the §280C election retroactively for 2022, 2023, and 2024 as part of the amended return process.

The deadline for this retroactive §280C election is July 4, 2026.

Key Reference Table

ItemDetail
OBBBA SignedJuly 4, 2025 (P.L. 119-21)
§174A Effective DateTax years beginning after December 31, 2024
Applicable IRS GuidanceRev. Proc. 2025-28 (replaces/supplements Rev. Proc. 2023-08 for 2025+)
Catch-Up Deduction — All TaxpayersDeduct unamortized 2022–2024 domestic R&E in full in 2025, or split equally across 2025 and 2026
Small Business Relief Threshold≤ $31 million average annual gross receipts (§448(c) test) for 2022–2024
Small Business Amended Return DeadlineJuly 4, 2026 (1 year from enactment)
§280C Retroactive Election Deadline (Small Business)July 4, 2026
Foreign R&E AmortizationStill 15 years — unchanged by OBBBA
§41 R&D Tax CreditUnchanged — still available, unaffected by §174A changes
Software Development CostsStill treated as R&E expenditures; eligible for §174A immediate expensing for domestic development

Frequently Asked Questions

No. The R&D tax credit under IRC §41 is unchanged by the OBBBA. The OBBBA only affects how R&D costs are treated as deductions under §174 — not whether you can claim a credit for them under §41.
No. For tax years beginning after December 31, 2024, domestic R&D expenditures are fully deductible in the year incurred under the new IRC §174A. The 5-year amortization requirement enacted by the TCJA no longer applies to domestic costs.
All taxpayers may take a catch-up deduction for any unamortized domestic R&D balances from 2022–2024 — either all in 2025, or split equally across 2025 and 2026. No Form 3115 is required; a statement attached to the return is sufficient per Rev. Proc. 2025-28.
Qualified small businesses (≤$31M average gross receipts under the §448(c) test for 2022–2024) may file amended returns for 2022, 2023, and 2024 to fully deduct previously capitalized domestic R&E costs. The deadline is July 4, 2026 — one year from enactment of the OBBBA.
Yes. The OBBBA did not change the treatment of foreign R&D expenditures. They remain subject to 15-year amortization under §174, as they were under the TCJA.
No. Per Rev. Proc. 2025-28, a statement attached to the federal tax return is sufficient. Form 3115 is not required for the transition to §174A expensing or for taking the catch-up deduction on prior unamortized balances.
Book Your Free Discovery Call